10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GLSI (Greenwich LifesciencesĀ Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Greenwich LifesciencesĀ Inc together

I guess you are interested in Greenwich LifesciencesĀ Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • šŸ“Š Fundamental Analysis (FA) – Greenwich LifesciencesĀ Inc’s Financial Insights
  • šŸ“ˆ Technical Analysis (TA) – Greenwich LifesciencesĀ Inc’s Price Targets

I'm going to help you getting a better view of Greenwich LifesciencesĀ Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Greenwich LifesciencesĀ Inc

I send you an email if I find something interesting about Greenwich LifesciencesĀ Inc.

1. Quick Overview

1.1. Quick analysis of Greenwich LifesciencesĀ Inc (30 sec.)










1.2. What can you expect buying and holding a share of Greenwich LifesciencesĀ Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.11
Expected worth in 1 year
$-0.22
How sure are you?
21.7%

+ What do you gain per year?

Total Gains per Share
$-0.33
Return On Investment
-2.9%

For what price can you sell your share?

Current Price per Share
$11.27
Expected price per share
$10.61 - $13.33
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Greenwich LifesciencesĀ Inc (5 min.)




Live pricePrice per Share (EOD)
$11.27
Intrinsic Value Per Share
$-9.77 - $-11.54
Total Value Per Share
$-9.67 - $-11.44

2.2. Growth of Greenwich LifesciencesĀ Inc (5 min.)




Is Greenwich LifesciencesĀ Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.4m$6.6m-$4m-158.6%

How much money is Greenwich LifesciencesĀ Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$2.5m-$1.9m-43.2%
Net Profit Margin-22,552.3%-11,411.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Greenwich LifesciencesĀ Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#695 / 853

Most Revenue
#690 / 853

Most Profit
#391 / 853

Most Efficient
#822 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Greenwich LifesciencesĀ Inc?

Welcome investor! Greenwich LifesciencesĀ Inc's management wants to use your money to grow the business. In return you get a share of Greenwich LifesciencesĀ Inc.

First you should know what it really means to hold a share of Greenwich LifesciencesĀ Inc. And how you can make/lose money.

Speculation

The Price per Share of Greenwich LifesciencesĀ Inc is $11.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Greenwich LifesciencesĀ Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Greenwich LifesciencesĀ Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.11. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Greenwich LifesciencesĀ Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.30-2.6%-0.33-2.9%-0.19-1.7%-0.22-2.0%-0.17-1.5%-0.15-1.3%
Usd Book Value Change Per Share0.010.1%-0.08-0.7%-0.09-0.8%-0.09-0.8%0.010.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.1%-0.08-0.7%-0.09-0.8%-0.09-0.8%0.010.1%0.000.0%
Usd Price Per Share9.07-11.05-14.14-12.38-18.00-15.66-
Price to Earnings Ratio-7.68--10.19--18.92--16.15--51.18--44.50-
Price-to-Total Gains Ratio972.05-145.93-1.51-13.82--83.91--83.91-
Price to Book Ratio85.88-71.17-32.03-38.75-29.23-25.42-
Price-to-Total Gains Ratio972.05-145.93-1.51-13.82--83.91--83.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.27
Number of shares88
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.080.01
Usd Total Gains Per Share-0.080.01
Gains per Quarter (88 shares)-7.160.94
Gains per Year (88 shares)-28.643.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-29-3904-6
20-57-6807-2
30-86-970112
40-115-1260156
50-143-15501910
60-172-18402214
70-200-21302618
80-229-24203022
90-258-27103426
100-286-30003730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.023.00.00.0%0.023.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%5.018.00.021.7%5.018.00.021.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%5.018.00.021.7%5.018.00.021.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Greenwich LifesciencesĀ Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.009-0.081+972%-0.088+1039%-0.095+1118%0.011-12%0.005+103%
Book Value Per Share--0.1060.188-44%0.487-78%0.537-80%0.993-89%0.850-88%
Current Ratio--1.8543.326-44%18.492-90%24.258-92%35.212-95%30.626-94%
Debt To Asset Ratio--0.5390.397+36%0.083+549%0.167+223%0.120+350%5.059-89%
Debt To Equity Ratio--1.1710.763+53%0.096+1120%0.293+299%0.200+485%0.174+572%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--121941212.000151410409.750-19%197617476.250-38%174806465.292-30%258226827.025-53%258226827.025-53%
Eps---0.295-0.330+12%-0.187-37%-0.224-24%-0.166-44%-0.147-50%
Ev To Ebitda Ratio---7.536-11.983+59%-20.959+178%-17.511+132%-58.484+676%-58.484+676%
Free Cash Flow Per Share---0.164-0.156-5%-0.124-24%-0.132-20%-0.112-31%-0.106-35%
Free Cash Flow To Equity Per Share--0.028-0.075+373%-0.068+348%-0.132+580%-0.010+136%0.024+17%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.542----------
Intrinsic Value_10Y_min---9.772----------
Intrinsic Value_1Y_max---0.619----------
Intrinsic Value_1Y_min---0.607----------
Intrinsic Value_3Y_max---2.269----------
Intrinsic Value_3Y_min---2.158----------
Intrinsic Value_5Y_max---4.413----------
Intrinsic Value_5Y_min---4.061----------
Market Cap153613481.000+20%123626821.000150648890.750-18%192732442.000-36%168680641.792-27%245410143.925-50%213400125.152-42%
Net Profit Margin----225.5230%-114.1190%-113.2140%-67.9290%-59.0680%
Operating Margin----227.1820%-117.0730%-114.7520%-68.8510%-59.8700%
Operating Ratio---227.245-100%117.073-100%114.773-100%68.864-100%59.881-100%
Pb Ratio106.714+20%85.88271.171+21%32.032+168%38.748+122%29.231+194%25.418+238%
Pe Ratio-9.541-24%-7.678-10.191+33%-18.920+146%-16.147+110%-51.179+567%-44.504+480%
Price Per Share11.270+20%9.07011.053-18%14.140-36%12.375-27%18.005-50%15.656-42%
Price To Free Cash Flow Ratio-17.197-24%-13.840-17.793+29%-31.904+131%-25.570+85%-58.773+325%-51.107+269%
Price To Total Gains Ratio1207.834+20%972.054145.929+566%1.511+64250%13.824+6931%-83.909+109%-83.909+109%
Quick Ratio---2.206-100%12.557-100%21.906-100%33.799-100%29.391-100%
Return On Assets---1.288-1.224-5%-0.366-72%-0.585-55%-0.370-71%-1.316+2%
Return On Equity---2.796-2.247-20%-0.402-86%-0.939-66%-0.583-79%-0.507-82%
Total Gains Per Share--0.009-0.081+972%-0.088+1039%-0.095+1118%0.011-12%0.005+103%
Usd Book Value--1439492.0002567126.000-44%6637329.750-78%7314641.500-80%13537690.700-89%11588029.435-88%
Usd Book Value Change Per Share--0.009-0.081+972%-0.088+1039%-0.095+1118%0.011-12%0.005+103%
Usd Book Value Per Share--0.1060.188-44%0.487-78%0.537-80%0.993-89%0.850-88%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--121941212.000151410409.750-19%197617476.250-38%174806465.292-30%258226827.025-53%258226827.025-53%
Usd Eps---0.295-0.330+12%-0.187-37%-0.224-24%-0.166-44%-0.147-50%
Usd Free Cash Flow---2233103.000-2125923.750-5%-1696305.750-24%-1794380.500-20%-1530510.050-31%-1440447.478-35%
Usd Free Cash Flow Per Share---0.164-0.156-5%-0.124-24%-0.132-20%-0.112-31%-0.106-35%
Usd Free Cash Flow To Equity Per Share--0.028-0.075+373%-0.068+348%-0.132+580%-0.010+136%0.024+17%
Usd Market Cap153613481.000+20%123626821.000150648890.750-18%192732442.000-36%168680641.792-27%245410143.925-50%213400125.152-42%
Usd Price Per Share11.270+20%9.07011.053-18%14.140-36%12.375-27%18.005-50%15.656-42%
Usd Profit---4025278.000-4498143.000+12%-2554601.250-37%-3061882.583-24%-2269497.500-44%-2007893.783-50%
Usd Revenue---903.000-100%1354.500-100%752.500-100%451.500-100%392.609-100%
Usd Total Gains Per Share--0.009-0.081+972%-0.088+1039%-0.095+1118%0.011-12%0.005+103%
 EOD+6 -2MRQTTM+13 -22YOY+10 -253Y+10 -255Y+6 -2910Y+12 -23

3.3 Fundamental Score

Let's check the fundamental score of Greenwich LifesciencesĀ Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.541
Price to Book Ratio (EOD)Between0-1106.714
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.854
Debt to Asset Ratio (MRQ)Less than10.539
Debt to Equity Ratio (MRQ)Less than11.171
Return on Equity (MRQ)Greater than0.15-2.796
Return on Assets (MRQ)Greater than0.05-1.288
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Greenwich LifesciencesĀ Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.569
Ma 20Greater thanMa 5011.496
Ma 50Greater thanMa 10011.490
Ma 100Greater thanMa 20010.545
OpenGreater thanClose11.900
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Greenwich LifesciencesĀ Inc

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.

Fundamental data was last updated by Penke on 2025-09-04 00:30:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitĀ Greenwich LifesciencesĀ Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Ā means thatĀ $0.00 for each $1Ā in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-22,552.3%+22,552.3%
TTM-22,552.3%YOY-11,411.9%-11,140.4%
TTM-22,552.3%5Y-6,792.9%-15,759.5%
5Y-6,792.9%10Y-5,906.8%-886.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--85.5%+85.5%
TTM-22,552.3%-171.0%-22,381.3%
YOY-11,411.9%-210.0%-11,201.9%
3Y-11,321.4%-289.9%-11,031.5%
5Y-6,792.9%-381.1%-6,411.8%
10Y-5,906.8%-520.3%-5,386.5%
4.3.1.2. Return on Assets

Shows howĀ efficientĀ Greenwich LifesciencesĀ Inc is using its assets to generate profit.

  • Above 5% is considered healthyĀ but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • -128.8% Return on Assets means thatĀ Greenwich LifesciencesĀ Inc generatedĀ $-1.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is -128.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -122.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.8%TTM-122.4%-6.4%
TTM-122.4%YOY-36.6%-85.8%
TTM-122.4%5Y-37.0%-85.4%
5Y-37.0%10Y-131.6%+94.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.8%-11.9%-116.9%
TTM-122.4%-11.9%-110.5%
YOY-36.6%-11.2%-25.4%
3Y-58.5%-12.0%-46.5%
5Y-37.0%-11.7%-25.3%
10Y-131.6%-13.8%-117.8%
4.3.1.3. Return on Equity

Shows how efficient Greenwich LifesciencesĀ Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • -279.6% Return on Equity means Greenwich LifesciencesĀ Inc generated $-2.80Ā for eachĀ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is -279.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -224.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-279.6%TTM-224.7%-54.9%
TTM-224.7%YOY-40.2%-184.5%
TTM-224.7%5Y-58.3%-166.4%
5Y-58.3%10Y-50.7%-7.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-279.6%-14.2%-265.4%
TTM-224.7%-15.2%-209.5%
YOY-40.2%-15.3%-24.9%
3Y-93.9%-16.9%-77.0%
5Y-58.3%-17.5%-40.8%
10Y-50.7%-19.6%-31.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Greenwich LifesciencesĀ Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresĀ how efficient Greenwich LifesciencesĀ Inc is operatingĀ .

  • Measures how much profit Greenwich LifesciencesĀ Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • An Operating Margin of 0.0%Ā means the company generated $0.00 Ā for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-22,718.2%+22,718.2%
TTM-22,718.2%YOY-11,707.3%-11,011.0%
TTM-22,718.2%5Y-6,885.1%-15,833.1%
5Y-6,885.1%10Y-5,987.0%-898.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--154.1%+154.1%
TTM-22,718.2%-280.2%-22,438.0%
YOY-11,707.3%-268.7%-11,438.6%
3Y-11,475.2%-281.5%-11,193.7%
5Y-6,885.1%-350.8%-6,534.3%
10Y-5,987.0%-530.7%-5,456.3%
4.3.2.2. Operating Ratio

Measures how efficient Greenwich LifesciencesĀ Inc is keepingĀ operating costsĀ low.

  • Below 1 is considered healthy (always compare toĀ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM227.245-227.245
TTM227.245YOY117.073+110.172
TTM227.2455Y68.864+158.381
5Y68.86410Y59.881+8.982
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.952-1.952
TTM227.2452.974+224.271
YOY117.0733.047+114.026
3Y114.7733.835+110.938
5Y68.8644.924+63.940
10Y59.8816.864+53.017
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Greenwich LifesciencesĀ Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Greenwich LifesciencesĀ Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toĀ Biotechnology industry mean).
  • A Current Ratio of 1.85Ā means the company has $1.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 1.854. The company is able to pay all its short-term debts. +1
  • The TTM is 3.326. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.854TTM3.326-1.472
TTM3.326YOY18.492-15.166
TTM3.3265Y35.212-31.886
5Y35.21210Y30.626+4.586
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8543.480-1.626
TTM3.3263.790-0.464
YOY18.4924.104+14.388
3Y24.2584.609+19.649
5Y35.2125.764+29.448
10Y30.6266.154+24.472
4.4.3.2. Quick Ratio

Measures if Greenwich LifesciencesĀ Inc is able to pay off Short-term Debt but only usingĀ theĀ most liquid assets.

  • Above 1 is considered healthy butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Quick Ratio of 0.00Ā means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.206-2.206
TTM2.206YOY12.557-10.351
TTM2.2065Y33.799-31.594
5Y33.79910Y29.391+4.408
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.938-2.938
TTM2.2063.291-1.085
YOY12.5573.928+8.629
3Y21.9064.393+17.513
5Y33.7995.837+27.962
10Y29.3916.549+22.842
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Greenwich LifesciencesĀ Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Ā of Greenwich LifesciencesĀ IncĀ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.54Ā means that Greenwich LifesciencesĀ Inc assets areĀ financed with 53.9% credit (debt) and the remaining percentage (100% - 53.9%)Ā is financed by its owners/shareholders.Ā 

Let's take a look of the Debt to Asset Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.539. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.397. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.539TTM0.397+0.142
TTM0.397YOY0.083+0.314
TTM0.3975Y0.120+0.277
5Y0.12010Y5.059-4.940
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5390.339+0.200
TTM0.3970.359+0.038
YOY0.0830.334-0.251
3Y0.1670.341-0.174
5Y0.1200.349-0.229
10Y5.0590.379+4.680
4.5.4.2. Debt to Equity Ratio

Measures ifĀ Greenwich LifesciencesĀ Inc is able toĀ pay off its debts by usingĀ shareholders equity.

  • Below 2 is considered healthy butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Debt to Equity ratio of 117.1% means that company has $1.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 1.171. The company is able to pay all its debts with equity. +1
  • The TTM is 0.763. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.171TTM0.763+0.408
TTM0.763YOY0.096+0.667
TTM0.7635Y0.200+0.563
5Y0.20010Y0.174+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1710.391+0.780
TTM0.7630.436+0.327
YOY0.0960.436-0.340
3Y0.2930.461-0.168
5Y0.2000.461-0.261
10Y0.1740.514-0.340
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresĀ how much money you payĀ for each share forĀ every $1 in earnings Greenwich LifesciencesĀ Inc generates.

  • Above 15 is considered overpriced butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A PE ratio of -7.68 means the investor is paying $-7.68Ā for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is -9.541. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.678. Based on the earnings, the company is expensive. -2
  • The TTM is -10.191. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.541MRQ-7.678-1.862
MRQ-7.678TTM-10.191+2.513
TTM-10.191YOY-18.920+8.730
TTM-10.1915Y-51.179+40.989
5Y-51.17910Y-44.504-6.676
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.541-2.539-7.002
MRQ-7.678-2.361-5.317
TTM-10.191-2.657-7.534
YOY-18.920-3.749-15.171
3Y-16.147-3.883-12.264
5Y-51.179-6.353-44.826
10Y-44.504-7.102-37.402
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is -17.197. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.840. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.793. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.197MRQ-13.840-3.357
MRQ-13.840TTM-17.793+3.953
TTM-17.793YOY-31.904+14.111
TTM-17.7935Y-58.773+40.980
5Y-58.77310Y-51.107-7.666
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.197-3.411-13.786
MRQ-13.840-2.951-10.889
TTM-17.793-3.614-14.179
YOY-31.904-4.421-27.483
3Y-25.570-5.258-20.312
5Y-58.773-8.587-50.186
10Y-51.107-9.639-41.468
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofĀ Greenwich LifesciencesĀ Inc is to cheap or to expensiveĀ compared to its book value.

  • At or below 1 is considered healthyĀ (always compare to Biotechnology industry mean).
  • A PB ratio of 85.88 means the investor is paying $85.88Ā for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is 106.714. Based on the equity, the company is expensive. -2
  • The MRQ is 85.882. Based on the equity, the company is expensive. -2
  • The TTM is 71.171. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD106.714MRQ85.882+20.831
MRQ85.882TTM71.171+14.711
TTM71.171YOY32.032+39.139
TTM71.1715Y29.231+41.940
5Y29.23110Y25.418+3.813
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD106.7142.206+104.508
MRQ85.8822.027+83.855
TTM71.1712.194+68.977
YOY32.0322.425+29.607
3Y38.7482.571+36.177
5Y29.2313.805+25.426
10Y25.4184.462+20.956
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Greenwich LifesciencesĀ Inc.

4.8.1. Institutions holding Greenwich LifesciencesĀ Inc

Institutions are holding 10.448% of the shares of Greenwich LifesciencesĀ Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc2.58390.0001352191-5653-1.5797
2025-06-30Vanguard Group Inc1.97360269002-1304-0.4824
2025-03-31Geode Capital Management, LLC1.00520.000113701029392.1921
2025-03-31CrƩdit Agricole S.A.0.63830.00268700000
2025-03-31Northern Trust Corp0.62090.000184633-2790-3.1914
2025-03-31State Street Corp0.551807520820002.7319
2025-06-30Marshall Wace Asset Management Ltd0.41190.000656142561420
2025-06-30STRS OHIO0.14670.00072000014007.5269
2025-06-30Charles Schwab Investment Management Inc0.1398019049420.221
2025-06-30Goldman Sachs Group Inc0.121016498164980
2025-03-31HighTower Advisors, LLC0.1130.000215407154070
2025-03-31Citadel Advisors Llc0.0977013314133140
2025-03-31Renaissance Technologies Corp0.09170.000212500-10200-44.9339
2025-03-31Bank of New York Mellon Corp0.082201120300
2025-03-31Rhumbline Advisers0.0710.00019673316848.701
2025-03-31Morgan Stanley - Brokerage Accounts0.0709547-4227-30.6883
2025-03-31Barclays PLC0.048706633-3015-31.25
2025-06-30New York State Common Retirement Fund0.0440.0001600000
2025-03-31Bank of America Corp0.039305362-1900-26.1636
2025-03-31MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.0.02670.000136381564.4802
Total 8.87740.00491210010+81977+6.8%

4.9.2. Funds holding Greenwich LifesciencesĀ Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31iShares Russell 2000 ETF1.11490.0027151959-2835-1.8315
2025-07-31Vanguard Total Stock Mkt Idx Inv1.10180.0001150177-3282-2.1387
2025-03-31PV BUYBACK USA Classe B USD0.63831.22818700000
2025-05-31Fidelity Small Cap Index0.46330.002563144-1962-3.0135
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.40140.000754715-16596-23.2727
2025-07-31iShares Russell 2000 Growth ETF0.35320.00454814100
2025-06-30Fidelity Extended Market Index0.22950.000731281-82-0.2615
2025-07-31Vanguard Russell 2000 ETF0.21380.002529143-2175-6.9449
2025-07-31State St Russell Sm CapĀ® Indx SL Cl I0.20910.00342850000
2025-07-31Schwab Small Cap Index0.11950.00271629000
2025-06-30NT R2000 Index Fund - NL0.11430.00231558200
2025-07-31iShares Micro-Cap ETF0.10040.01791368500
2025-06-30NT R2000 Index Fund - DC - NL - 30.09110.002312423-25-0.2008
2025-07-31iShares Russell 2000 Small-Cap Idx Instl0.08730.0031190200
2025-06-30Fidelity Total Market Index0.07790.00011061500
2025-06-30Extended Equity Market Fund K0.07580.000610336-206-1.9541
2025-06-30Russell 2500ā„¢ Index Fund F0.06590.0008898990.1002
2025-06-30Nuveen Small Cap Blend Idx R60.05960.0022812200
2025-06-30Goldman Sachs Absolute Ret Trckr Instl0.05950.00128106285654.4
2025-06-30Fidelity Series Total Market Index0.05630.0001767500
Total 5.63291.2784767785-24298-3.2%

5.3. Insider Transactions

Insiders are holding 51.295% of the shares of Greenwich LifesciencesĀ Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-04-25Snehal PatelBUY36009.88
2025-04-17Snehal PatelBUY54008.98
2025-04-07Snehal PatelBUY36009.1
2025-04-04Snehal PatelBUY55008.73
2025-01-10Snehal PatelBUY250012.51
2025-01-07Snehal PatelBUY180013.75
2025-01-02Snehal PatelBUY200011.97
2024-12-30Snehal PatelBUY320011.12
2024-11-21Jaye ThompsonBUY100012.91
2024-09-26Snehal PatelBUY150014.63
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,125
Total Liabilities1,686
Total Stockholder Equity1,439
 As reported
Total Liabilities 1,686
Total Stockholder Equity+ 1,439
Total Assets = 3,125

Assets

Total Assets3,125
Total Current Assets3,125
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 3,125
Total Current Assets  (as reported)3,125
Total Current Assets  (calculated)3,125
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,686
Long-term Liabilities0
Total Stockholder Equity1,439
Total Current Liabilities
Accounts payable 1,296
Total Current Liabilities  (as reported)1,686
Total Current Liabilities  (calculated)1,296
+/- 389
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)1,439
Total Stockholder Equity (calculated)0
+/- 1,439
Other
Capital Stock13
Common Stock Shares Outstanding 13,371
Net Invested Capital 1,439
Net Working Capital 1,439



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
109
0
0
0
27
26
281
6,274
28,677
30,420
29,815
28,920
27,217
19,755
17,199
15,648
13,477
11,919
10,951
9,150
6,995
5,510
7,228
5,825
4,094
2,751
3,125
3,1252,7514,0945,8257,2285,5106,9959,15010,95111,91913,47715,64817,19919,75527,21728,92029,81530,42028,6776,2742812627000109
   > Total Current Assets 
85
85
0
0
7
7
263
6,257
28,660
30,405
29,801
28,906
27,204
19,743
17,188
15,638
13,468
11,911
10,944
9,144
6,989
5,506
7,225
5,825
4,092
2,750
3,125
3,1252,7504,0925,8257,2255,5066,9899,14410,94411,91113,46815,63817,18819,74327,20428,90629,80130,40528,6606,25726377008585
       Cash And Cash Equivalents 
85
-85
0
0
7
7
7
6,214
28,660
30,405
29,801
28,906
27,204
19,743
17,188
15,638
13,468
11,911
10,944
9,144
6,989
5,506
7,225
5,822
4,092
2,750
3,125
3,1252,7504,0925,8227,2255,5066,9899,14410,94411,91113,46815,63817,18819,74327,20428,90629,80130,40528,6606,21477700-8585
       Short-term Investments 
0
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001700
       Other Current Assets 
0
0
0
0
0
0
256
43
0
0
0
28,906
0
0
0
0
0
0
0
0
0
0
4
3
0
1
0
01034000000000028,90600043256000000
   > Long-term Assets 
23
-85
0
0
20
19
18
17
16
15
14
14
13
12
11
10
9
8
7
6
5
4
4
3
2
1
0
0123445678910111213141415161718192000-8523
       Intangible Assets 
23
0
0
0
20
19
18
17
16
15
14
14
13
12
11
10
9
8
7
6
5
4
4
3
2
1
0
0123445678910111213141415161718192000023
       Other Assets 
0
0
0
0
0
0
0
17
16
0
0
0
13
12
11
10
9
8
7
0
0
0
0
3
0
1
0
010300007891011121300016170000000
> Total Liabilities 
10,229
0
0
0
1,377
1,447
1,738
1,616
1,045
673
653
455
385
241
229
238
263
236
302
297
294
390
1,353
842
1,560
1,439
1,686
1,6861,4391,5608421,3533902942973022362632382292413854556536731,0451,6161,7381,4471,37700010,229
   > Total Current Liabilities 
729
0
0
0
1,377
1,447
1,738
1,616
1,045
673
653
455
385
241
229
238
263
236
302
297
294
390
1,353
842
1,560
1,439
1,686
1,6861,4391,5608421,3533902942973022362632382292413854556536731,0451,6161,7381,4471,377000729
       Short-term Debt 
0
0
0
0
635
635
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000006356350000
       Accounts payable 
278
0
0
0
730
749
635
635
275
609
628
296
221
221
221
221
221
221
80
10
256
126
1,114
775
1,178
827
1,296
1,2968271,1787751,1141262561080221221221221221221296628609275635635749730000278
       Other Current Liabilities 
451
0
0
0
12
63
1,103
981
770
64
25
159
164
20
8
17
42
15
222
287
0
264
239
68
0
611
0
0611068239264028722215421782016415925647709811,1036312000451
   > Long-term Liabilities 
9,500
0
0
0
0
0
0
0
0
0
0
0
221
221
221
221
221
221
0
0
0
0
0
0
0
0
0
000000000221221221221221221000000000009,500
> Total Stockholder Equity
-10,120
-10,120
0
0
-1,350
-1,421
-1,458
4,658
27,631
29,747
29,162
28,464
26,832
19,514
16,970
15,410
13,214
11,684
10,650
8,853
6,700
5,121
5,875
4,983
2,534
1,312
1,439
1,4391,3122,5344,9835,8755,1216,7008,85310,65011,68413,21415,41016,97019,51426,83228,46429,16229,74727,6314,658-1,458-1,421-1,35000-10,120-10,120
   Common Stock
1
0
0
0
8
23
9
12
13
13
13
13
13
13
13
13
13
13
13
13
0
13
13
13
0
13
0
013013131301313131313131313131313131292380001
   Retained Earnings -73,437-69,412-66,153-58,113-55,444-52,838-50,365-47,618-45,226-43,598-41,473-38,682-36,363-35,617-33,648-31,287-30,424-29,674-29,077-27,926-27,669-27,459-27,214000-23,789
   Capital Surplus 
0
0
0
0
0
0
0
0
56,695
59,408
59,573
59,738
60,466
55,118
53,320
54,080
0
55,269
55,863
0
0
0
0
0
0
0
0
0000000055,86355,269054,08053,32055,11860,46659,73859,57359,40856,69500000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
13,663
0
0
0
25,853
26,009
26,201
32,572
56,695
59,408
59,573
59,738
60,466
55,118
53,320
54,080
54,674
55,269
55,863
56,458
0
57,946
61,307
63,083
0
70,711
0
070,711063,08361,30757,946056,45855,86355,26954,67454,08053,32055,11860,46659,73859,57359,40856,69532,57226,20126,00925,85300013,663



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4
Gross Profit-4-4
 
Operating Income (+$)
Gross Profit-4
Operating Expense-16,012
Operating Income-16,012-16,015
 
Operating Expense (+$)
Research Development12,952
Selling General Administrative3,060
Selling And Marketing Expenses0
Operating Expense16,01216,012
 
Net Interest Income (+$)
Interest Income223
Interest Expense-0
Other Finance Cost-0
Net Interest Income223
 
Pretax Income (+$)
Operating Income-16,012
Net Interest Income223
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,789-16,235
EBIT - interestExpense = -15,789
-15,789
-15,789
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-15,789-15,789
Earnings Before Interest and Taxes (EBITDA)-15,785
 
After tax Income (+$)
Income Before Tax-15,789
Tax Provision-0
Net Income From Continuing Ops-15,789-15,789
Net Income-15,789
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,012
Total Other Income/Expenses Net223-223
 

Technical Analysis of Greenwich LifesciencesĀ Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Greenwich LifesciencesĀ Inc. The general trend of Greenwich LifesciencesĀ Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Greenwich LifesciencesĀ Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Greenwich LifesciencesĀ Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportĀ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceĀ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Greenwich LifesciencesĀ Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.89 < 12.95 < 13.33.

The bearish price targets are: 10.70 > 10.70 > 10.61.

Know someone who trades $GLSI? Share this with them.šŸ‘‡

Greenwich LifesciencesĀ Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theĀ moving averageĀ of the selected period.

  • Moving averages are laggingĀ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Greenwich LifesciencesĀ Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Greenwich LifesciencesĀ Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theĀ momentumĀ of theĀ selected period based on two moving averages.

  • MACD is aĀ lagging momentumĀ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Greenwich LifesciencesĀ Inc. The current macd is -0.05497652.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Greenwich LifesciencesĀ Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Greenwich LifesciencesĀ Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Greenwich LifesciencesĀ Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Greenwich LifesciencesĀ Inc Daily Moving Average Convergence/Divergence (MACD) ChartGreenwich LifesciencesĀ Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Greenwich LifesciencesĀ Inc. The current adx is 23.19.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Greenwich LifesciencesĀ Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Greenwich LifesciencesĀ Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsĀ the current trend.
  • ShowsĀ potential entry signals.
  • ShowsĀ Ā potential exit signals.
  • Can be used to placeĀ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Greenwich LifesciencesĀ Inc. The current sar is 10.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Greenwich LifesciencesĀ Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumĀ indicator, meaning the signals are instant.
  • RangesĀ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Greenwich LifesciencesĀ Inc. The current rsi is 47.57. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Greenwich LifesciencesĀ Inc Daily Relative Strength Index (RSI) ChartGreenwich LifesciencesĀ Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesĀ a certain price to multiple prices ranging over time.

  • LeadingĀ momentumĀ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesĀ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Greenwich LifesciencesĀ Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Greenwich LifesciencesĀ Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Greenwich LifesciencesĀ Inc Daily Stochastic Oscillator ChartGreenwich LifesciencesĀ Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Ā the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Greenwich LifesciencesĀ Inc. The current cci is -33.45885972.

Greenwich LifesciencesĀ Inc Daily Commodity Channel Index (CCI) ChartGreenwich LifesciencesĀ Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Greenwich LifesciencesĀ Inc. The current cmo is -7.44389617.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Greenwich LifesciencesĀ Inc Daily Chande Momentum Oscillator (CMO) ChartGreenwich LifesciencesĀ Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Ā Shows the current price relative to the highest high over the last 14 days.
Ā 

  • Lagging momentum indicator
  • Ranging between 0 andĀ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Greenwich LifesciencesĀ Inc. The current willr is -75.05422993.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Greenwich LifesciencesĀ Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Greenwich LifesciencesĀ Inc Daily Williams %R ChartGreenwich LifesciencesĀ Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldĀ 

Score

Let's take a look at the Bollinger Bands of Greenwich LifesciencesĀ Inc.

Greenwich LifesciencesĀ Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Greenwich LifesciencesĀ Inc. The current atr is 0.6849242.

Greenwich LifesciencesĀ Inc Daily Average True Range (ATR) ChartGreenwich LifesciencesĀ Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Ā Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Greenwich LifesciencesĀ Inc. The current obv is 1,576,400.

Greenwich LifesciencesĀ Inc Daily On-Balance Volume (OBV) ChartGreenwich LifesciencesĀ Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Greenwich LifesciencesĀ Inc. The current mfi is 61.90.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Greenwich LifesciencesĀ Inc Daily Money Flow Index (MFI) ChartGreenwich LifesciencesĀ Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Greenwich LifesciencesĀ Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Greenwich LifesciencesĀ Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Greenwich LifesciencesĀ Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.569
Ma 20Greater thanMa 5011.496
Ma 50Greater thanMa 10011.490
Ma 100Greater thanMa 20010.545
OpenGreater thanClose11.900
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Greenwich LifesciencesĀ Inc with someone you think should read this too:
  • Are you bullish or bearish on Greenwich LifesciencesĀ Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Greenwich LifesciencesĀ Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Greenwich LifesciencesĀ Inc

I send you an email if I find something interesting about Greenwich LifesciencesĀ Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Greenwich LifesciencesĀ Inc.

Receive notifications about Greenwich LifesciencesĀ Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.